DrugPatentWatch Database Preview
EFFIENT Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Effient, and what generic alternatives are available?
Effient is a drug marketed by Eli Lilly And Co and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has thirty-two patent family members in twenty-six countries.
The generic ingredient in EFFIENT is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the prasugrel hydrochloride profile page.
Summary for EFFIENT
| International Patents: | 32 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 46 |
| Clinical Trials: | 42 |
| Patent Applications: | 17 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for EFFIENT |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for EFFIENT |
| DailyMed Link: | EFFIENT at DailyMed |
Generic Entry Opportunity Date for EFFIENT
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for EFFIENT
| Drug Class | P2Y12 Platelet Inhibitor |
| Mechanism of Action | P2Y12 Receptor Antagonists |
| Physiological Effect | Decreased Platelet Aggregation |
Medical Subject Heading (MeSH) Categories for EFFIENT
Synonyms for EFFIENT
| [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxo-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate hydrochloride |
| [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride |
| 2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone Hydrochloride |
| 2-Acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride |
| 389574-19-0 |
| 5-((1RS)-2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridin-2-yl acetate hydrochloride |
| 5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride |
| 574C190 |
| AB0009955 |
| AC-24004 |
| ACM389574190 |
| AK124410 |
| AKOS022185568 |
| AM20090719 |
| AN-6869 |
| CAS-389574-19-0 |
| CHEMBL1201773 |
| CP0133 |
| CS-1785 |
| CTK8E7134 |
| D05597 |
| DSSTox_CID_28993 |
| DSSTox_GSID_49067 |
| DSSTox_RID_83258 |
| DTXSID1049067 |
| EBD36213 |
| Effient (TN) |
| Ethanone, 2-(2-(acetyloxy)-6,7-dihydrothieno(3,2-c)pyridin-5(4H)-yl)-1-cyclopropyl-2-(2-fluorophenyl)-, hydrochloride |
| Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-, hydrochloride (1:1) |
| FT-0656362 |
| HY-15284A |
| JALHGCPDPSNJNY-UHFFFAOYSA-N |
| LY 640315 |
| MFCD11867705 |
| MolPort-006-170-137 |
| NCGC00188690-01 |
| NCGC00188690-02 |
| Prasugrel (hydrochloride) |
| Prasugrel HCl |
| Prasugrel hydrochloride |
| Prasugrel hydrochloride (JAN/USAN) |
| Prasugrel Hydrochloride [USAN] |
| Prasugrel Hydrochloride(Discontinued) |
| Prasugren hydrochloride |
| PubChem23807 |
| RT-015128 |
| s4637 |
| SC-20618 |
| SCHEMBL246128 |
| Tox21_113621 |
| Tox21_113621_1 |
US Patents and Regulatory Information for EFFIENT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly And Co | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-001 | Jul 10, 2009 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Eli Lilly And Co | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-002 | Jul 10, 2009 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Eli Lilly And Co | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-001 | Jul 10, 2009 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Eli Lilly And Co | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-002 | Jul 10, 2009 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Eli Lilly And Co | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-001 | Jul 10, 2009 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Eli Lilly And Co | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-001 | Jul 10, 2009 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Eli Lilly And Co | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-002 | Jul 10, 2009 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Expired US Patents for EFFIENT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Eli Lilly And Co | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-001 | Jul 10, 2009 | ➤ Sign Up | ➤ Sign Up |
| Eli Lilly And Co | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-002 | Jul 10, 2009 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for EFFIENT
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 5 mg and 10 mg | ➤ Subscribe | ➤ Sign Up |
see a sample report or, see our see our flat-rate plans
International Patents for EFFIENT
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Czech Republic | 297570 | ➤ Sign Up |
| Hungary | 0400644 | ➤ Sign Up |
| European Patent Office | 1350511 | ➤ Sign Up |
| Cyprus | 1108626 | ➤ Sign Up |
| Norway | 20032902 | ➤ Sign Up |
| Denmark | 1350511 | ➤ Sign Up |
| South Korea | 100692934 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for EFFIENT
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB09/032 | United Kingdom | ➤ Sign Up | PRODUCT NAME: PRASUGREL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/08/503/001 20090225; UK EU/1/08/503/002 20090225; UK EU/1/08/503/003 20090225; UK EU/1/08/503/004 20090225 |
| 00397 | Netherlands | ➤ Sign Up | PRODUCT NAME: PRASUGREL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225 |
| C0031 | France | ➤ Sign Up | PRODUCT NAME: PRASUGREL; NAT. REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225; FIRST REGISTRATION: EU/1/08/503/001/-014 20090225 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
